Table 3. Cox Regression Analysis for Overall Survival in 68 Patients with Lung Cancer.
Variable | Univariate | Multivariate | ||
P | HR (95% Cl) | P | HR (95% Cl) | |
Age | 0.143 | 0.96 (0.93–1.02) | - | - |
Histological differentiation | 0.186 | 1.30 (0.88–1.93) | 0.208 | 1.59 (0.77–3.33) |
T factor (T1vs T2,3,4) | 0.413 | 1.33 (0.67–2.64) | 0.640 | 0.81 (0.33–1.97) |
Regional lymph node (N0,1 vs N2,3) | 0.019 | 1.99 (1.10–3.58) | 0.025 | 1.95 (1.08–3.52) |
Pathologic stage (I, II vs III, IV) | 0.021 | 2.13 (1.12–4.04) | 0.024 | 1.73 (1.07–2.80) |
VEGF (≤Median vs>Median) | 0.037 | 1.75 (1.02–2.98) | 0.053 | 1.95 (0.99–5.00) |
TSP-1(≤Median vs>Median) | 0.088 | 1.52 (0.91–3.14) | 0.289 | 0.99 (0.63–2.09) |
NPAA (≤Median vs>Median) | 0.012 | 3.30 (1.30–8.40) | 0.018 | 3.04 (1.08–8.55) |
Bold values indicate “significant difference (P<0.05).”
HR, hazard ratio; Cl, confidence interval.